A clinical 56-day open label, multi-center study to evaluate the PK and safety of LYR-210 in adult subjects with chronic rhinosinusitis (CRS)

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 31 Oct 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Nov 2022 Results reporting pharmacokinetics and safety data published in the American Journal of Rhinology and Allergy
30 Jun 2021 According to a Lyra Therapeutics media release, data from this trial will be presented during a podium presentation at the upcoming American Rhinologic Society Annual meeting in October 2021.
30 Jun 2021 According to a Lyra Therapeutics media release, Randall Ow is investigator of this trial.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com